Bacterial DNA translocation holds increased insulin resistance and systemic inflammatory levels in morbid obese patients

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 7, 2014, Pages 2575-2583

  Ortiz, Sergio ^a   Zapater, Pedro ^a,b,c   Estrada, José Luis ^a   Enriquez, Pablo ^a   Rey, Monica ^a   Abad, Ángel ^a   Such, José ^b,c   Lluis, Félix ^a   Francés, Rubén ^b,c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ENDOTOXIN;

ADULT; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL TRANSLOCATION; BLOOD SAMPLING; BODY MASS; CYTOKINE RESPONSE; DIET THERAPY; DISEASE ASSOCIATION; DNA DETERMINATION; ENDOTOXIN DETECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROUX Y ANASTOMOSIS; SEQUENCE ANALYSIS; STOMACH BYPASS; WEIGHT REDUCTION;

ADULT; BACTERIAL TRANSLOCATION; BARIATRIC SURGERY; BODY MASS INDEX; CYTOKINES; DNA, BACTERIAL; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; WEIGHT LOSS;

EID: 84904052550     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4483     Document Type: Article

References (30)

1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-846. (Pubitemid 46024990)
2. Faintuch J, Marques PC, Bortolotto LA, Faintuch JJ, Cecconello I. Systemic inflammation and cardiovascular risk factors: are morbidly obese subjects different? Obes Surg. 2008;18(7):854-862.
3. Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14(5):589-600. (Pubitemid 38716577)
4. Frühbeck G. Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol Biol. 2008;456:1-22.
5. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18(2):139-143.
6. Zalesin KC, Franklin BA, Miller WM, Peterson ED, McCullough PA. Impact of obesity on cardiovascular disease. Med Clin North Am. 2011;95(5):919-937.
7. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218-1240.
8. Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: the effects of weight loss. Nutr Res Rev. 2008;21(2):117-133.
9. Vázquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90(1):316-322. (Pubitemid 40116674)
10. Apovian CM, Bigornia S, Mott M, et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol. 2008;28(9):1654-1659.
11. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-867. (Pubitemid 46024993)
12. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111-1119. (Pubitemid 40629025)
13. Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord. 2002;26(5):659-662. (Pubitemid 34499286)
14. Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23(6):1042-1047. (Pubitemid 36713558)
15. Johnson AR, Milner JJ, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev. 2012;249(1):218-238.
16. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012;71(2):298-306.
17. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022-1023. (Pubitemid 46018512)
18. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-1031. (Pubitemid 46018515)
19. Sabaté JM, Jouët P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18(4):371-377.
20. Jouet P, Coffin B, Sabate JM. Small intestinal bacterial overgrowth in patients with morbid obesity. Dig Dis Sci. 2011;56(2):615.
21. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191- 2192. (Pubitemid 28549174)
22. Such J, Francés R, Muñoz C, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, non-neutrocytic ascites. Hepatology. 2002;36(1):135-141. (Pubitemid 34700770)
23. Francés R, Benlloch S, Zapater P, et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology. 2004;39(2):484-491. (Pubitemid 38222190)
24. Roth RI, Levin FC, Levin J. Optimization of detection of bacterial endotoxin in plasma with the Limulus test. J Lab Clin Med. 1990;116(2):153-161. (Pubitemid 20269808)
25. Guarner C, González-Navajas JM, Sánchez E, et al. The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology. 2006;44(3):633-639. (Pubitemid 44433719)
26. Francés R, Zapater P, González-Navajas JM, et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology. 2008;47(3):978-985. (Pubitemid 351449689)
27. Virkamäki A, Puhakainen I, Koivisto VA, Vuorinen-Markkola H, Yki-Järvinen H. Mechanisms of hepatic and peripheral insulin resistance during acute infections in humans. J Clin Endocrinol Metab. 1992;74(3):673-679.
28. Virkamäki A, Yki-Järvinen H. Mechanisms of insulin resistance during acute endotoxemia. Endocrinology. 1994;134(5):2072-2078. (Pubitemid 24142945)
29. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87-91. (Pubitemid 23036092)
30. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science. 1996;271(5249):665-668. (Pubitemid 26052915)